Screener
CVS Health CVS Gain on sale of business and assets
Gain on sale of business and assets at other companies
Other financials
Where this comes from
Reported directly by CVS Health in its filing.
Tagged under the XBRL concept us-gaap:GainLossOnSaleOfBusiness.
The source filing: CVS Health’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 6:33 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000064803-26-000098
| In millions | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Adjustments required to reconcile net income to net cash provided by operating activities: | ||
| Depreciation and amortization | 2,241 | 2,325 |
| Stock-based compensation | 442 | 262 |
| Loss on sale of subsidiary | — | 236 |
| Deferred income taxes and other items | (241) | (283) |
| Change in operating assets and liabilities, net of effects from acquisitions: | ||
| Accounts receivable, net | (533) | (4,139) |
| Inventories | 1,624 | 671 |
Item 1.Financial Statements
FAQ
- What is CVS Health's gain on sale of business and assets?
- CVS Health (CVS) reported gain on sale of business and assets of $0 in Q2 2026.
- What does gain on sale of business and assets mean?
- Gain on sale of business and assets
Ask your AI about CVS Health's gain on sale of business and assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude